SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-24-001192
Filing Date
2024-01-30
Accepted
2024-01-30 16:39:08
Documents
1
Period of Report
2023-12-07

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP gsk-form4_120723.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP gsk-form4_120723.xml 4 3494
  Complete submission text file 0001999371-24-001192.txt   5704
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GSK plc (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 24578734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)